• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The COVID pandemic's lingering impact on clinical trials.

作者信息

Ledford Heidi

出版信息

Nature. 2021 Jul;595(7867):341-342. doi: 10.1038/d41586-021-01569-9.

DOI:10.1038/d41586-021-01569-9
PMID:34183846
Abstract
摘要

相似文献

1
The COVID pandemic's lingering impact on clinical trials.新冠疫情对临床试验的持续影响。
Nature. 2021 Jul;595(7867):341-342. doi: 10.1038/d41586-021-01569-9.
2
The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology.2019年冠状病毒病（COVID-19）大流行对病理学中社交互动的影响。
Arch Pathol Lab Med. 2021 Sep 1;145(9):1049-1050. doi: 10.5858/arpa.2021-0221-LE.
3
Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.评论格雷戈里等人的文章《糖尿病群体中新冠病毒疾病严重程度增加两倍：1型和2型糖尿病大流行影响的前瞻性分析》。《糖尿病护理》2021年；44:526 - 532。
Diabetes Care. 2021 May;44(5):e102. doi: 10.2337/dc20-3119.
4
Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.对关于格雷戈里等人的评论的回应。《糖尿病护理》2021年；44:526 - 532。《糖尿病群体中COVID - 19严重程度增加两倍：1型和2型糖尿病大流行影响的前瞻性分析》
Diabetes Care. 2021 May;44(5):e103-e104. doi: 10.2337/dci21-0005.
5
Wuhan market was epicentre of pandemic's start, studies suggest.研究表明，武汉市场是疫情开始的中心。
Nature. 2022 Mar;603(7899):15-16. doi: 10.1038/d41586-022-00584-8.
6
The Pandemic's Agenda.疫情的议程。
Ann Fam Med. 2022 Jan-Feb;20(1):1-2. doi: 10.1370/afm.2786.
7
The Untold Toll - The Pandemic's Effects on Patients without Covid-19.未知的代价——疫情对非新冠患者的影响
N Engl J Med. 2020 Jun 11;382(24):2368-2371. doi: 10.1056/NEJMms2009984. Epub 2020 Apr 17.
8
COVID super-immunity: one of the pandemic's great puzzles.新冠超级免疫力：大流行中的重大谜题之一。
Nature. 2021 Oct;598(7881):393-394. doi: 10.1038/d41586-021-02795-x.
9
Asymptomatic infection is the pandemic's dark matter.无症状感染是这场大流行的暗物质。
Proc Natl Acad Sci U S A. 2021 Sep 21;118(38). doi: 10.1073/pnas.2114054118.
10
Care of the Seriously Ill Patient with SARS-CoV-2.严重急性呼吸综合征冠状病毒 2 感染患者的护理。
Med Clin North Am. 2022 Nov;106(6):949-960. doi: 10.1016/j.mcna.2022.08.002. Epub 2022 Aug 10.

引用本文的文献

1
Coronary Revascularization Guided With Fractional Flow Reserve or Instantaneous Wave-Free Ratio: A 5-Year Follow-Up of the DEFINE FLAIR Randomized Clinical Trial.基于血流储备分数或瞬时无波比值指导的冠状动脉血运重建：DEFINE FLAIR随机临床试验的5年随访
JAMA Cardiol. 2025 Jan 1;10(1):25-31. doi: 10.1001/jamacardio.2024.3314.
2
The Odyssey of HOMER: Comparative Effectiveness Research on Medication for Opioid Use Disorder During the COVID-19 Pandemic.荷马的奥德赛：COVID-19 大流行期间阿片类药物使用障碍药物治疗的对比效果研究。
Ann Fam Med. 2024 Sep-Oct;22(5):444-450. doi: 10.1370/afm.3149.
3
The death of a neurotrauma trial lessons learned from the prematurely halted randomized evaluation of surgery in elderly with traumatic acute subdural hematoma (RESET-ASDH) trial.

本文引用的文献

1
The COVID-19 pandemic and new clinical trial activations.新型冠状病毒肺炎大流行与新临床试验的开展。
Trials. 2021 Apr 8;22(1):260. doi: 10.1186/s13063-021-05219-3.
一项神经创伤试验的死亡教训：从针对老年创伤性急性硬膜下血肿患者手术的随机评估（RESET-ASDH）试验过早中止中吸取的经验教训
Brain Spine. 2024 Jul 18;4:102903. doi: 10.1016/j.bas.2024.102903. eCollection 2024.
4
Evaluating implementation of a community-focused patient navigation intervention at an NCI-designated cancer center using RE-AIM.使用 RE-AIM 评估 NCI 指定癌症中心的以社区为中心的患者导航干预措施的实施情况。
BMC Health Serv Res. 2024 Apr 29;24(1):550. doi: 10.1186/s12913-024-10919-y.
5
Field based research in the era of the pandemic in resource limited settings: challenges and lessons for the future.资源有限环境下大流行时代的实地研究：未来的挑战与经验教训。
Front Public Health. 2024 Feb 29;12:1309089. doi: 10.3389/fpubh.2024.1309089. eCollection 2024.
6
"Click and mortar" opportunities for digitization and consumerism in trials.“点击与 mortar”：试验中的数字化和消费主义机遇。
Contemp Clin Trials. 2023 Sep;132:107304. doi: 10.1016/j.cct.2023.107304. Epub 2023 Jul 20.
7
Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.非 COVID-19 英国临床试验与 COVID-19 大流行：影响、挑战及可能的解决方案。
Trials. 2023 Jun 22;24(1):424. doi: 10.1186/s13063-023-07414-w.
8
Impact of COVID-19 pandemic on nonpharmacological pain management trials in military and veteran healthcare settings: an evaluation informed by implementation science.COVID-19 大流行对军事和退伍军人医疗保健环境中非药物性疼痛管理试验的影响：基于实施科学的评估。
Transl Behav Med. 2023 Aug 11;13(8):601-611. doi: 10.1093/tbm/ibad015.
9
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.先行走，再奔跑：来自 PROCLAIM 研究的可行性挑战和经验教训，该研究是一项关于 COVID-19 期间米索前列醇预防复发性艰难梭菌的多中心随机对照试验。
Anaerobe. 2023 Apr;80:102699. doi: 10.1016/j.anaerobe.2023.102699. Epub 2023 Jan 23.
10
Revisiting the clinical trial history and regulatory mechanisms in Nepal in the context of COVID-19 pandemic.在新冠疫情背景下重新审视尼泊尔的临床试验历史与监管机制。
Contemp Clin Trials Commun. 2022 Dec;30:101038. doi: 10.1016/j.conctc.2022.101038. Epub 2022 Nov 12.